You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
The firm will provide information on the seroprevalence of SARS-CoV-2, sharing results with demographic information and analysis in collaboration with the CDC.
The recently renamed company will use the project to develop a new version of its next-generation sequencing assay for cancer mutational analysis.
National TB control programs may now order the T-spot.TB, a blood test for TB screening, through the Stop TB Partnership - GDF procurement mechanism.
The collaborators aim to develop lung cancer molecular diagnostic tests using molecular, clinical, and imaging-based artificial intelligence technologies.
Synlab will make a gastrointestinal testing service that is based on Microba's gut microbiome test available to its network of doctors and clinics.
Caris will sequence DNA and RNA for certain cancer patients and potentially help Merus enroll cancer patients with NRG1 fusions in the Phase I/II eNRGy trial for zenocutuzumab.
The population genomics firm said that it can provide 2,000 COVID-19 PCR tests per day out of its San Diego lab while it awaits FDA Emergency Use Authorization.
First Genetics will market its F-Genetics NGS System and IVD assays to Russian laboratories for reproductive health testing and cancer diagnostics.
The new company, FonesLife, will use Somalogic's SomaScan technology for health monitoring and assessing patient illness risk.
The companies will work together to bring Guardant360 through regulatory approval and commercialize it as a CDx for Janssen's amivantamab.